introduction human respiratory syncytial virus hrsv member family paramyxoviridae known primary cause lower respiratory tract infection lrti including pneumonia bronchitis—in infant child well elderly immunocompromised individual rsv enveloped virus contains single-stranded negative-sense rna genome size 15.2 yet two major rsv antigenic subtypes identified rsv-a rsv-b exhibiting differential sequence divergence throughout genome rsv-a seen prevalent rsv-b however two subtypes coexist thrive owing rsv reinfections common throughout life infected individual indicating cross-immunity distinct strain partial rsv severely affect immunocompromised infant well geriatric population weakened immune system implicated virus infection considered globally second largest cause death child one year age rsv-associated acute lrti responsible around million serious respiratory infection globally every year according world health organization resulting million hospitalization 60,000 death child year age 6.7 death infant younger year-old rsv infects cell lining human respiratory pathway including ciliated epithelial cell cause upper lower respiratory tract complication influenza-like disease lrti display clinical symptom serious rsv infection consequently past two decade rsv become major focus vaccination study decrease morbidity lower respiratory tract infection despite failure first rsv vaccine trial many vaccine developed investigated one licensed yet commercial use addition vaccine development approach use rsv anti-infective drug palliative treatment option explored potential strategy fight rsv infection merely two approved rsv antiviral currently available include palivizumab humanized preventive monoclonal antibody aerosolized ribavirin therapy two antiviral help alleviate symptom rsv infection ideal prophylactic use furthermore efficacy ribavirin improving outcome severe rsv patient remains uncertain hence available research highlight urgent need develop effective rsv vaccine successfully combat infection caused virus study immunoinformatics approach used generate polyvalent epitope-based vaccine blueprint capable inducing substantial immune response rsv-a rsv-b type targeted four highly virulent protein designing subunit vaccine phosphoprotein protein nucleoprotein protein fusion glycoprotein protein major surface glycoprotein protein protein mediates fusion attachment virus target cell along protein thus facilitating viral entry whereas protein surround viral genome rsv protein vital component viral rna-dependent rna polymerase complex necessary proper replication transcription rsv hence study aimed identify potential epitope protein rsv goal designing polyvalent vaccine capable stimulating immune response combat rsv infection result protein sequence identification retrieval ncbi database rsv viral strain query protein identified following four rsv-a rsv-b query protein including protein protein protein retrieved uniprot online database uniprot accession number length query protein listed table table list targeted protein uniprot accession number full size table epitope prediction sorting promising epitope selected protein found antigenic initial antigenicity analysis biophysical property analysis query protein listed table afterwards rsv-a protein selected model prediction t-cell b-cell epitope iedb server construction polyvalent vaccine meaning epitope selected using rsv-a protein fully conserved epitope taken therefore epitope confer immunity selected strain rsv-a rsv-b based ranking top mhc class-i cytotoxic lymphocyte ctl mhc class-ii helper lymphocyte htl epitope well top b-cell epitope length ten amino acid taken consideration analysis following criterion selected filter best epitope included high antigenicity non-allergenicity non-toxicity conservancy human proteome non-homology furthermore cytokine i.e. ifn-γ il-4 il-10 inducing ability htl epitope also considered determine whether produce least one cytokine finally epitope met criterion listed promising epitope table later used construction vaccine also analysis transmembrane topology tmhmm v2.0 server promising epitope revealed pefhgedannr sfkedptpsdnpfs evapeyrhdspd vfpsdefdasisqvnek ipnkkpgkktttkptkkptlkttkkdpkpqttkskevpttkp epitope exposed outside table list epitope eventually selected construction vaccine full size table potential epitope protein protein protein protein listed table respectively population coverage cluster analysis epitope mhc allele population coverage analysis showed 85.70 87.92 world population covered mhc class-i class-ii allele epitope respectively 84.62 world population covered combined mhc class-i class-ii india highest percentage population coverage ctl epitope 87.56 well htl epitope 93.51 china highest percentage population coverage ctl htl epitope combination 91.80 fig hand cluster analysis potential allele mhc class mhc class may interfere predicted epitope rsv query protein also conducted fig show heat map tree map representing cluster heat map represents strength interaction allele red zone indicating stronger interaction yellow zone indicating weaker interaction hand tree map show hierarchical clustering allele larger cluster represented larger rectangle smaller cluster smaller rectangle together visualization provide insight relationship mhc allele aid understanding genetic diversity population figure result population coverage analysis promising epitope selected mhc allele full size image vaccine construction biophysical property analysis vaccine sequence constructed linking promising t-cell b-cell epitope appropriate linkers additionally hbd-3 adjuvant padre sequence conjugated appropriate position schematic presentation vaccine sequence illustrated fig later biophysical property analysis vaccine observed vaccine possessed potent antigenic property non-allergenic vaccine high theoretical basic 9.75 reasonably adequate half-life mammalian cell coli cell culture system gravy value vaccine considered significantly negative -0.362 additionally server sol-pro protein-sol also shown vaccine protein soluble attesting negative value instability index protein found 27.55 indicating vaccine quite stable extinction coefficient aliphatic index vaccine also found high value 45,770 80.85 respectively figure designing vaccine construct schematic representation potential vaccine construct linkers eaaak aay gpgpg padre sequence adjuvant hbd-3 epitope ctl htl lbl sequential appropriate manner sequence vaccine protein letter bold represent linker sequence full size image vaccine structure prediction refinement validation secondary structure vaccine protein analyzed revealing coil structure largest number amino acid β-strand showed lowest percentage prediction four different server depicted fig compared amino acid percentage α-helix β-strand coil structure listed table server showed similar prediction adjuvant appeared generate potential variation vaccine protein secondary structure figure result secondary structure prediction vaccine prispred prediction gor prediction sopma prediction simpa96 prediction full size image table result secondary structure analysis vaccine construct full size table model vaccine generated using raptorx online server significantly good quality low p-value 8.71e-05 four domain homology modeling performed using 1kj6a template protein data bank additionally vaccine structure modeled using modeller improve quality shown fig figure prediction refinement validation tertiary structure vaccine tertiary structure vaccine construct modelled refined visualized raptorx galaxyweb server biovia discovery studio visualizer 17.2 respectively result ramachandran plot analysis generated procheck server quality score z-score graph generated prosa-web server refined vaccine construct ramachandran plot orange deep yellow coloured region allowed region light yellow region generously allowed region white region outlier region glycine residue represented triangle full size image afterwards modelled structure vaccine refined validated using ramachandran plot z-score plot ramachandran plot revealed 93.5 amino acid vaccine protein preferred region 6.3 additional approved region 0.2 generously permitted region residue disallowed region z-score modelled vaccine 5.08 overall protein validation analysis revealed reasonably consistent structure refined form shown fig structure deemed suitable molecular docking simulation study analysis conformational b-lymphocytic epitope disulfide engineering vaccine ellipro server used predict conformational b-cell epitope vaccine protein analysis revealed three non-contiguous b-cell epitope encompassing total amino acid residue value ranging 0.506 0.675 conformational epitope varied size ranging residue three-dimensional representation conformational b-cell epitope designed multi-epitope-based rsv vaccine epitope residue presented fig listed table disulfide bond vaccine structure predicted using dbd2 server disulfide engineering analysis three pair amino acid bond energy 2.2 kcal/mol selected cys cys ala lys tyr thr selected pair amino acid used form mutant vaccine dbd2 server contains potential disulfide bond within fig figure graphical representation predicted conformational b-cell epitope modelled vaccine indicated yellow coloured ball-shaped structure full size image post-translational modification analysis post-translational modification analysis vaccine four n-glycosylation site sixty-three o-glycosylation site predicted vaccine construct sequence finding suggest significant amount glycosylation may occurred inside predicted vaccine construct might improve vaccine efficacy immunogenicity addition vaccine protein sequence ninety-six phosphorylated residue i.e. serine residue threonine tyrosine phosphorylation site according netphos v2.0 server output server-provided plot containing n-glycosylation site phosphorylation given fig analysis protein–protein docking protein–protein docking analysis performed demonstrate vaccine ability interact various crucial molecular immune component i.e. tlrs docked using cluspro 2.0 demonstrated high binding affinity target tlrs studied using zdock server vaccine protein also displayed strong interaction tlrs lowest energy level obtained docking vaccine construct tlr-1 tlr-2 tlr-3 tlr-4 tlr-9 986.1 1236.7 1084.4 1260.8 1226.4 respectively lowest energy level vaccine tlrs indicated highest binding affinity molecular dynamic simulation study mm-pbsa calculation simulation effective method analysis biological system provides many mechanistic insight possible behavior system simulated biological environment gromacs 2020.4 used carry production phase analysis resulting trajectory undertaken understand structural property interaction different tlrs predicted vaccine protein molecular level snapshot equilibrated structure tlr-vaccine complex snapshot last trajectory shown fig visual inspection trajectory different time interval suggested side chain vaccine make different interaction chain tlrs except tlr1 vaccine side chain found interacting side chain chain figure snapshot equilibrated initial system last trajectory vaccine bound complex tlr1 tlr2 tlr3 tlr4 tlr9 snapshot surface representation cartoon representation shown full size image root mean square deviation rmsd analysis give insight backbone atom move relative initial equilibrated position lower rmsd better stability corresponding system present work measured rmsd backbone atom entire protein–protein complex tlrs vaccine figure show rmsd investigated system evaluation root mean square fluctuation rmsf provides insight possible change secondary structure protein investigation present work rmsf side chain atom residue system measured tlr-vaccine system multiple chain rmsf evaluation performed chain complex understand residue involved key contact rmsf tlr side-chain atom shown fig rmsf chain tlrs given fig analysis radius gyration provides overall measurement compactness system result total shown fig analysis non-bonded interaction hydrogen bond quite challenging protein–protein complex side chain protein participate hydrogen bond interaction hydrogen bond analysis trajectory performed h-bond module gromacs key residue interface tlr chain vaccine chain analyzed chimerax program result hydrogen bond analysis shown fig figure result molecular dynamic simulation study root mean square deviation investigated system root mean square fluctuation side chain atom vaccine radius gyration vaccine full size image immune simulation study immune simulation study designed vaccine conducted using c-immsimm server forecast activation adaptive immunity well immune interaction epitope specific target analysis exhibited primary immune reaction vaccine could stimulated substantially administration vaccine demonstrated steady rise level different immunoglobulin i.e. igg1 igg2 igg igm antibody fig also expected concentration active cell fig plasma cell fig helper cell fig cytotoxic cell fig could steadily increase reflecting vaccine capacity create high secondary immune response healthy immune memory however fig demonstrates concentration regulatory cell would gradually decrease throughout phase injection represents decrease suppression vaccine-induced immunity regulatory cell comparison rise dendritic cell macrophage concentration showed apc competent presentation antigen fig simulation result also predicted constructed vaccine could generate numerous form cytokine including ifn-γ il-23 il-10 ifn-β critical cytokine producing immune response viral infection fig therefore overall immune simulation analysis showed administration proposed polyvalent multi-epitope vaccine would able elicit robust immunogenic response figure c-immsimm representation immune simulation designed vaccine construct immunoglobulin immunocomplex response vaccine inoculation line hued black specific subclass indicated coloured line elevation b-cell population throughout three injection rise plasma b-cell population throughout injection elevation helper t-cell population throughout three injection decrease regulatory lymphocyte concentration throughout three injection augmentation cytotoxic lymphocyte population throughout injection augmentation population active dendritic cell macrophage respectively per state throughout three injection rise concentration different type cytokine throughout three injection full size image codon adaptation silico cloning interpretation vaccine mrna secondary structure protein sequence vaccine optimized in-silico cloning plasmid construction using jcat server codon adaptation index cai value 0.98 content 50.23 fall within desired range sequence graphically illustrated codon adaptation shown fig codon-adapted vaccine dna sequence inserted eaei styi restriction site petite vector plasmid resulting recombinant plasmid named cloned_petite fig later secondary structure vaccine mrna predicted using mfold rnafold server minimum free energy score predicted mfold rnafold server 549.30 kcal/mol 526.30 kcal/mol respectively score consistent vaccine mrna secondary structure depicted fig figure in-silico cloning vaccine sequence petite plasmid vector codon sequence final vaccine presented red generated jcat server petite expression vector black full size image discussion study used immunoinformatics technique design polyvalent epitope-based vaccine rsv subtypes targeting four antigenic protein virus protein antigenicity biophysical property predicted found antigenic high aliphatic index extinction coefficient negative gravy value suggesting stability light-absorption ability hydrophilic nature potential t-cell b-cell epitope selected protein crucial activating cytotoxic t-cells helper t-cells b-cells generate effective immune response analyzed study identify potential epitope elicit immune response individual diverse human leukocyte antigen hla genotype epitope prediction multiple allele considered high polymorphism variability hla allele combination among individual significantly impact ability present respond specific epitope emphasizing need epitope prediction multiple hla allele approach essential developing effective vaccine immunotherapy target wider population rigorous screening process conducted identify epitope highly conserved antigenic non-allergenic non-toxic screening process critical ensuring vaccine safe use broad-spectrum activity rsv-a rsv-b virus specifically htl epitope demonstrated ability elicit cytokine production ifn-γ il-4 il-10 ultimately chosen development vaccine cytokine known play crucial role modulating immune response viral infection rsv ifn-γ pro-inflammatory cytokine strongly linked respiratory syncytial virus rsv pathogenesis study suggest ifn-γ play dual role control rsv infection limiting viral replication preventing airway obstruction contrast il-10 anti-inflammatory cytokine demonstrated regulate immune response viral infection reducing production pro-inflammatory cytokine limiting tissue damage caused excessive inflammation il-4 also anti-inflammatory cytokine play crucial role regulation immune response rsv infection promoting th2 cell differentiation antibody production stimulates production immunoglobulin ige th2 cytokine il-5 il-13 help clearing virus preventing infection therefore cytokine like ifn-γ il-10 il-4 given special consideration selection htl epitope vaccine since may play crucial role mediating communication various immune cell vaccine administered mhc cluster analysis result presented indicates mhc class-i class-ii allele epitope considered separately population coverage globally suggests vaccine potential provide protection large proportion world population mhc class-i class-ii allele epitope combined coverage drop slightly still representing significant proportion population moreover selected epitope compared overall population exhibit greater individual percentage coverage suggests vaccine potential effective worldwide rsv infection important consideration developing vaccine since disease like rsv affect people globally vaccine provide broad protection across different population valuable preventing controlling spread disease vaccine construction selected four linkers eaaak aay gpgpg conjugation promising rsv epitope based ability provide optimal spacing flexibility stability conjugate eaaak linker contains glutamic acid lysine residue aay contains alanine tyrosine residue gpgpg contains glycine proline residue contains lysine residue linkers chosen enhance solubility flexibility stability immunogenicity conjugate innate antimicrobial peptide hbd-3 selected adjuvant improve antigenicity immunogenicity durability longevity vaccine peptide chosen due potential induce expression co-stimulatory molecule surface monocyte myeloid dendritic cell well ability prevent fusion virus stimulate various immune response additionally padre sequence incorporated strengthen immunogenic reaction vaccine constructing vaccine antigenicity allergenicity biophysical property assessed revealing vaccine protein suitable refinement validation process result indicate constructed vaccine protein basic hydrophilic stable protein desirable biophysical property high theoretical negative gravy value low instability index high extinction coefficient aliphatic index suggest protein soluble likely undergo conformational change degradation highly stable property make vaccine protein promising candidate modelling refinement validation secondary structure analysis vaccine showed higher abundance coiled region lower amount β-strand indicating greater stability conservation predicted vaccine model tertiary structure predicted refined resulting high p-value 8.71e−05 four domain protein indicating accurate prediction effort increase stability vaccine structure disulfide engineering conducted identify potential disulfides increase protein thermal stability following prediction refinement tertiary structure vaccine analysis disulfide engineering posttranslational modification conducted aim analysis provide insight future synthesis vaccine potential increase vaccine stability immunogenicity disulfide engineering three pair amino acid vaccine identified could improve protein stability facilitate study protein dynamic interaction vaccine construct analysed posttranslational modification identified four n-glycosylation site sixty-three o-glycosylation site ninety-six phosphorylated residue incorporating modification vaccine design optimize vaccine efficacy improve protection viral infection posttranslational modification including glycosylation phosphorylation acetylation play significant role vaccine effectiveness immunological response glycosylation particular enhance antigenicity immunogenicity phosphorylation acetylation promote immune recognition improve protein stability proposed rsv vaccine analyzed using molecular docking revealed strong interaction toll-like receptor tlrs critical rsv pathogenesis tlr4 showed lowest energy level vaccine indicating highest interaction tlr2 tlr9 also demonstrated high interaction tlr2 tlr1 tlr6 tlr3 tlr4 critical tlrs rsv pathogenesis tlr2/1 tlr2/6 complex enhancing early innate inflammatory response controlling viral replication vaccine strong affinity target tlrs suggests may induce robust immune response upon administration following molecular docking analysis simulation performed examine molecular stability five docked vaccine-tlr complex response external force exerted surrounding environment tlr1-vaccine complex found stable tlr4-vaccine complex higher rmsd despite similar number chain rmsf analysis revealed residue range 190–240 480–530 large magnitude fluctuation complex tlr3-vaccine complex showing slightly larger fluctuating side chain others non-bonded interaction analysis showed tlr1-vaccine complex highest number hydrogen bond around formed till around time interval steadily lowered around hydrogen bond till thereafter rose hydrogen bond tlr4-vaccine complex lowest number hydrogen bond formed around compared system overall study showed docked vaccine-tlr complex reasonable stability tlr1-vaccine complex highest stability among five complex actual residue involved hydrogen bond formation investigated last trajectory tabulated table proposed vaccine found induce humoral cell-mediated immune response resulting increased memory plasma cell cytotoxic helper cell various antibody activation helper cell led strong adaptive immunity antigen presentation cytokine profile enriched gradual increase mucosal immunoglobulin predicted crucial respiratory virus like rsv vaccine also showed potential decrease regulatory cell suppression vaccine-induced immunity overall vaccine provides broad-spectrum immunity viral invasion stimulates immune system predominantly mucosal surface result suggest proposed vaccine construct likely effective vaccination finally study aimed identify potential codon required generating recombinant plasmid express vaccine coli strain k12 mass manufacturing codon adaptation silico cloning study performed result showed significantly good result cai value 0.98 content 50.23 indicating potential high-level expression optimized vaccine dna sequence inserted petite plasmid vector containing sumo tag could promote purification downstream processing vaccine stability vaccine mrna secondary structure predicted using mfold rnafold server showing much lower minimal free energy indicating predicted vaccine could stable upon transcription overall finding suggest proposed vaccine construct potential mass production could stable making promising candidate development however research vitro vivo study required strongly verify immunogenicity efficacy stability safety diverse biophysical property proposed vaccine method high throughput immunoinformatics approach vaccine designing illustrated step-by-step process fig figure step-by-step procedure immunoinformatics molecular dynamic approach used vaccine designing study full size image protein sequence identification retrieval existing literature review national center biotechnology information ncbi http database rsv-a rsv-b virus identified selected along target protein i.e. protein protein protein protein sequence target protein selected strain i.e. rsv strain rsv strain extracted uniprot http database fasta format ncbi protein database collection swissprot pir prf pdb sequence also includes genbank refseq tpa translation elucidated coding region prediction t-cell b-cell epitope epitope prediction antigenicity biophysical property target protein analysed using online antigenicity prediction tool vaxijen v2.0 http antigenicity target protein sequence predicted prediction precision parameter threshold kept 0.4 subsequently protparam tool expasy server http used determine biophysical property target protein afterwards t-cell b-cell epitope prediction performed using immune epitope database iedb http contains extensive experimental data antibody epitope prediction ctl epitope several hla allele i.e. hla 01:01 hla 03:01 hla 11-01 hla 02:01 hla 02:06 hla 29:02 recommended iedb netmhcpan 4.0 prediction method used default prediction method selection server iedb recommended utilizes best available technique specific mhc molecule based availability predictor observes predicted performance specific allele prediction htl epitope drb1 03:01 drb1 04:01 drb1 15:01 drb3 01:01 drb5 01:01 drb4 01:01 allele recommended iedb 2.22 prediction method used henceforth based ranking top-scored htl ctl epitope found common selected corresponding hla allele considered analysis parameter retained opting default t-cell epitope prediction later b-cell epitope protein predicted using bepipred linear epitope prediction method 2.0 maintaining default parameter thus top-scored lbl epitope containing ten amino acid primarily regarded potential candidate analysis also conformational b-cell epitope modeled structure vaccine predicted using iedb ellipro online server http using default parameter minimum score 0.5 maximum distance angstrom assessment antigenicity allergenicity toxicity topology prediction epitope step several method predicting conservancy antigenicity allergenicity toxicity used evaluate initially predicted t-cell b-cell epitope ass conservancy chosen epitope conservancy prediction method iedb server http used also antigenicity determination tool vaxijen v2.0 used determination antigenicity epitope two different tool used i.e allertop v2.0 http allergenfp v1.0 http obtain highest precision prediction allergenicity tool based auto cross-covariance acc transformation protein sequence uniform equal-length vector however allertop v2.0 server better 88.7 prediction accuracy allergenfp v1.0 server 87.9 addition toxinpred http server used predict toxicity epitope using support vector machine svm prediction method keep default parameter finally using tmhmm v2.0 server http tmhmm-2.0 transmembrane topology prediction epitope performed predict whether epitope exposed inside outside keeping parameter default value tmhmm algorithm called n-best 1-best case predict probable location orientation transmembrane helix sequence cytokine inducing capacity prediction epitope induction capacity predicted htl epitope interferon-γ ifn-γ determined using ifnepitope http server based analyzing dataset includes ifn-γ inducing non-inducing peptide server determines probable ifn-γ inducing epitope determine ifn-γ inducing capacity design module hybrid motif svm prediction approach used addition il-4 il-10 inducing htl epitope property determined using server il4pred http il10pred http svm method used server default threshold value kept 0.2 0.3 respectively conservancy human proteome homology prediction conservancy analysis specified epitope conducted using iedb server epitope conservancy analysis module afterwards homology human proteome epitope determined blast blastp protein module blast tool http homo sapiens taxid used comparison keeping default parameter e-value cut-off 0.05 set epitope selected non-homologous pathogen peptide showed hit e-value inclusion threshold epitope found highly antigenic non-allergenic non-toxic fully conserved non-homologous human proteome finally considered promising epitope selected epitope used construction vaccine population coverage cluster analysis epitope mhc allele iedb server http used analyzing population coverage promising epitope across several hla allele various region around world denominated mhc restriction cell response polymorphic hla combination considered analysis parameter maintained default condition study furthermore evaluate relationship selected mhc allele cluster analysis mhc allele done using online tool mhccluster 2.0 http mhccluster-2.0 study 50,000 peptide used retained bootstrap measurement retained hla supertype mhc class-i hla-dr mhc class-ii representative chosen vaccine construction biophysical property analysis promising antigenic epitope linked create fusion peptide using adjuvant linkers human beta-defensin-3 hbd-3 used adjuvant sequence linked epitope eaaak linkers epitope also appended pan hla-dr epitope padre sequence conjugation ctl htl lbl epitope aay gpgpg linkers used respectively vaccine construct prepared antigenicity sequence measured using vaxijen v2.0 server keeping threshold value fixed 0.4 finding vaxijen v2.0 server cross-checked antigenpro module scratch protein predictor http holding default parameter achieve better prediction precision three different online method used accurately perform allergenicity vaccine i.e algpred http allertop v2.0 allergenfp v1.0 ensure optimum prediction precision biophysical property vaccine analysed protparam thereafter solubility vaccine construct also estimated alongside biophysical property study solpro module scratch protein predictor http validated protein-sol server http parameter server maintained default value solubility review secondary tertiary structure prediction vaccine construct vaccine construct subjected secondary structure prediction following biophysical property analysis several online tool used preserve default parameter i.e psipred http using psipred 4.0 prediction method gor http page=/npsa/npsa_gor4.html sopma http page=/npsa/npsa_sopma.html simpa96 http page=/npsa/npsa_simpa96.html predict percentage quantity amino acid helix β-sheet coil structure formation server considered reliable quick effective moreover modelling vaccine construct carried using raptorx online server http using easy powerful template-based method server predicts tertiary structure query protein raptorx deep learning method enable distance-based protein folding refinement validation tertiary structure vaccine galaxyweb server http using galaxyrefine module used refine predicted model vaccine improving resolution resembles native protein structure server dynamic simulation refinement approach tested casp10 refine tertiary protein structure furthermore validation refined protein carried analyzing ramachandran plot created procheck http tool along procheck protein validation another online platform prosa-web http also used z-score express consistency query protein structure created procheck server vaccine protein disulfide engineering analysis experiment disulfide design dbd v12.2 http online tool used predict location design disulfide bond within vaccine protein tool developed using computational approach predict protein structure algorithm server accurately estimate torsion angle based 5the cβ–cβ distance using geometric model derived native disulfide bond caf-cβ-sγ angle allowed tolerance dbd2 server based wide range found native disulfides facilitate ranking process dbd2 estimate energy value potential disulfide mutant pdb file may generated selected disulfides angle held 87° 97° experiment cast various putative disulfides generated using default angle 97° 30° 87° 30° additionally angle caf-cβ-sγ set default value 114.6° finally allow disulfide bridge formation residue pair energy 2.2 kcal/mol selected mutated cysteine residue post-translational modification analysis posttranslational modification analysis vaccine construct comprising b-cell t-cell epitope netnglyc-1.0 http netoglyc4.0 http netphos-3.1 http server utilized netnglyc server artificial neural network predict n-glycosylation site human protein examining sequence context asn-xaa-ser/thr sequons netoglyc server predicts mucin type galnac o-glycosylation site mammalian protein using neural network server provides list probable glycosylation site input sequence together position sequence prediction confidence score using ensemble neural network netphos 3.1 server predicts serine threonine tyrosine phosphorylation site eukaryotic protein analysis protein–protein docking vaccine protein docked several toll-like receptor tlrs protein–protein docking analysis study different tlrs docked vaccine protein i.e tlr-1 pdb 6nih tlr-2 pdb 3a7c tlr-3 pdb 2a0z tlr-4 pdb 4g8a tlr9 pdb 3wpf cluspro v2.0 http used conduct docking lower energy score corresponds stronger binding affinity based following equation cluspro server calculates energy score 0.40erep+ -0.40eatt 600eelec +1.00edars repulsion attraction energy owing van der waals interaction denoted rep attr respectively whereas elec signifies electrostatic energy component decoy pairwise structure-based potential represented dars reference state dars method furthermore another round docking carried using zdock server http rigid-body protein–protein docking tool employ combination shape complementarity electrostatics statistical potential term scoring fast fourier transform algorithm enable efficient global docking search grid current benchmark version accelerating protein docking zdock utilizing advanced convolution library zdock achieves high predictive accuracy protein–protein docking benchmark success top prediction rigid-body instance molecular dynamic simulation study mm-pbsa calculation docked complex zdock server used simulation complex protein–protein nature multiple chain simulation computationally expensive performed hpc cluster bioinformatics resource application facility braf c-dac pune gromacs 2020.4 simulation package charmm-36 force field parameter employed prepare topology protein chain system tlr along bound vaccine solvated single point charge water model dodecahedron unit cell neutralized addition counter-ions solvated system initially energy minimized relieve steric clash steepest descent criterion threshold fmax kj/mol reached energy minimized system equilibrated constant volume temperature condition using modified berendsen thermostat constant volume pressure berendsen barostat equilibrated system later subjected production phase simulation modified berendsen thermostat parrinello-rahman barostat used covalent bond restrained using lincs algorithm long-range electrostatic interaction energy measured cut-off particle mesh ewald method pme resulting trajectory analyzed root mean square deviation rmsd protein backbone atom root mean square fluctuation rmsf side chain atom individual chain protein complex radius gyration several hydrogen bond formed vaccine protein chain respective tlr protein chain immune simulation study forecast immunogenicity immune response profile proposed vaccine immune simulation analysis performed immune simulation study c-immsim server http used predict real-life immune interaction using machine learning technique pssm position-specific scoring matrix experiment variable except time step kept default parameter however time step retained time step injection time number simulation step set thus three injection four-week interval administered induce recurrent antigen exposure codon adaptation silico cloning within coli system java codon adaptation tool jcat server http used codon optimization optimized codon sequence analyzed expression parameter codon adaptation index cai gc-content optimum cai value 1.0 score 0.8 considered acceptable optimum content range silico cloning simulation petite vector plasmid selected contains small ubiquitin-like modifier sumo tag well polyhistidine 6x-his tag vaccine protein sequence reverse-translated optimized dna sequence server eaei styi restriction site incorporated n-terminal c-terminal site respectively newly adapted dna sequence inserted eaei styi restriction site petite vector using snapgene restriction cloning software http confirm expression vaccine prediction vaccine mrna secondary structure two server i.e mfold http q=mfold rnafold http used mrna secondary structure prediction server thermodynamically predict mrna secondary structure provide generated structure minimum free energy kcal/mol analyze mrna folding secondary vaccine structure optimized dna sequence first taken jcat server converted via dna rna- protein tool http possible rna sequence rna sequence gathered tool utilized prediction mfold rnafold server using default setting parameter